• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Fatty change in moderately and poorly differentiated hepatocellular carcinoma on MRI: a possible mechanism related to decreased arterial flow.

作者信息

Asayama Y, Nishie A, Ishigami K, Ushijima Y, Takayama Y, Okamoto D, Fujita N, Kubo Y, Aishima S, Yoshizumi T, Honda H

机构信息

Departments of Advanced Imaging and Interventional Radiology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.

Clinical Radiology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.

出版信息

Clin Radiol. 2016 Dec;71(12):1277-1283. doi: 10.1016/j.crad.2016.04.020. Epub 2016 Jul 7.

DOI:10.1016/j.crad.2016.04.020
PMID:27210243
Abstract

AIM

To clarify the frequency of fatty change in moderately and poorly differentiated hepatocellular carcinomas (mHCCs and pHCCs) and its relationship to arterial blood flow.

MATERIALS AND METHODS

One hundred and thirty-six surgically resected HCC lesions were studied. All patients had undergone dynamic magnetic resonance imaging (MRI) with chemical-shift-encoded water-fat imaging (CSI). The presence of fat was identified by a signal drop-off on CSI and confirmed at pathology. Lesions were classified into four groups in the arterial phase; G1, hypointense; G2, isointense; G3, slightly and heterogeneously hyperintense; G4, markedly and homogeneously hyperintense. The number of cumulative arteries (CAs) in the tumours in the pathology examination were counted.

RESULTS

A fat component was observed significantly more frequently in the pHCCs (13/21; 61.9%) compared to the mHCCs (32/101; 31.7%; p=0.013). The numbers of lesions in each group were as follows: (G1, G2, G3, G4) = (18, 9, 23, 4) in the HCCs with fat; (1, 6, 24, 51) in the HCCs without fat (p<0.001); (5, 5, 18, 4) in the mHCCs with fat; (0, 3, 19, 47) in the mHCCs without fat (p<0.001); (11, 0, 2, 0) in the pHCCs with fat; (0, 2, 3, 3) in the pHCCs without fat (p=0.001). The number of CAs in the fat-containing HCCs (5.5±2.9) was significantly lower than that in the HCCs without fat (10.8±5.3; p<0.001).

CONCLUSION

A fat component was more commonly observed in the pHCCs than in the mHCCs. The present results showed a possible mechanism of fatty change in mHCCs and pHCCs in relation to decreased arterial blood supply.

摘要

相似文献

1
Fatty change in moderately and poorly differentiated hepatocellular carcinoma on MRI: a possible mechanism related to decreased arterial flow.
Clin Radiol. 2016 Dec;71(12):1277-1283. doi: 10.1016/j.crad.2016.04.020. Epub 2016 Jul 7.
2
Apparent diffusion coefficient of hepatocellular carcinoma on diffusion-weighted imaging: Histopathologic tumor grade versus arterial vascularity during dynamic magnetic resonance imaging.弥散加权成像上肝细胞癌的表观弥散系数:动态磁共振成像时的病理肿瘤分级与动脉血管生成。
PLoS One. 2018 May 11;13(5):e0197070. doi: 10.1371/journal.pone.0197070. eCollection 2018.
3
Poorly versus moderately differentiated hepatocellular carcinoma: vascularity assessment by computed tomographic hepatic angiography in correlation with histologically counted number of unpaired arteries.
J Comput Assist Tomogr. 2007 Mar-Apr;31(2):188-92. doi: 10.1097/01.rct.0000236417.82395.57.
4
MRI proton density fat fraction for estimation of tumor grade in steatotic hepatocellular carcinoma.磁共振质子密度脂肪分数在评估脂肪变性肝细胞癌肿瘤分级中的应用。
Eur Radiol. 2023 Dec;33(12):8974-8985. doi: 10.1007/s00330-023-09864-x. Epub 2023 Jun 27.
5
Arterial blood supply of hepatocellular carcinoma and histologic grading: radiologic-pathologic correlation.肝细胞癌的动脉血供与组织学分级:影像学-病理学相关性
AJR Am J Roentgenol. 2008 Jan;190(1):W28-34. doi: 10.2214/AJR.07.2117.
6
Contrast-enhanced ultrasound with perflubutane microbubble agent: evaluation of differentiation of hepatocellular carcinoma.对比增强超声应用全氟丁烷微泡造影剂:肝细胞癌的鉴别诊断评估。
AJR Am J Roentgenol. 2011 Feb;196(2):W123-31. doi: 10.2214/AJR.10.4242.
7
Differentiation of hepatocellular carcinoma from non-hepatocellular malignant tumours of liver by chemical-shift MRI at 3 T.3T 化学位移 MRI 鉴别肝细胞癌与肝脏非肝细胞性恶性肿瘤。
Clin Radiol. 2019 Oct;74(10):797-804. doi: 10.1016/j.crad.2019.06.006. Epub 2019 Jul 9.
8
Small hepatocellular carcinomas in cirrhosis: differences in contrast enhancement effects between helical CT and MR imaging during multiphasic dynamic imaging.肝硬化中的小肝细胞癌:螺旋CT与磁共振成像在多期动态成像过程中对比增强效果的差异
Magn Reson Imaging. 2008 Jan;26(1):65-71. doi: 10.1016/j.mri.2007.04.007. Epub 2007 Jun 13.
9
Sequential hemodynamic change in hepatocellular carcinoma and dysplastic nodules: CT angiography and pathologic correlation.肝细胞癌和发育异常结节的序贯血流动力学变化:CT血管造影与病理对照
AJR Am J Roentgenol. 2002 Apr;178(4):885-97. doi: 10.2214/ajr.178.4.1780885.
10
[The magnetic resonance and histological correlations in hepatocellular carcinoma].[肝细胞癌的磁共振成像与组织学相关性]
Radiol Med. 1994 Jan-Feb;87(1-2):90-5.

引用本文的文献

1
Fat fraction quantification with MRI estimates tumor proliferation of hepatocellular carcinoma.利用磁共振成像进行脂肪分数定量可评估肝细胞癌的肿瘤增殖情况。
Front Oncol. 2024 Apr 11;14:1367907. doi: 10.3389/fonc.2024.1367907. eCollection 2024.
2
Current Status of Cancer Genomics and Imaging Phenotypes: What Radiologists Need to Know.癌症基因组学和影像学表型的现状:放射科医生需要了解的内容。
Radiol Imaging Cancer. 2023 Nov;5(6):e220153. doi: 10.1148/rycan.220153.
3
Fat-containing hepatocellular carcinoma in patients with cirrhosis: proposal of a diagnostic modification regarding enhancement characteristics.
肝硬化患者含脂肝细胞癌:关于增强特征的诊断修改建议。
Eur Radiol. 2024 Apr;34(4):2283-2293. doi: 10.1007/s00330-023-10236-8. Epub 2023 Oct 11.
4
Fat fraction and R2 * values of various liver masses: Initial experience with 6-point Dixon method on a 3T MRI system.各种肝脏肿块的脂肪分数和R2 *值:3T MRI系统上六点Dixon法的初步经验。
Eur J Radiol Open. 2023 Aug 17;11:100519. doi: 10.1016/j.ejro.2023.100519. eCollection 2023 Dec.
5
MRI proton density fat fraction for estimation of tumor grade in steatotic hepatocellular carcinoma.磁共振质子密度脂肪分数在评估脂肪变性肝细胞癌肿瘤分级中的应用。
Eur Radiol. 2023 Dec;33(12):8974-8985. doi: 10.1007/s00330-023-09864-x. Epub 2023 Jun 27.
6
Contrast-Enhanced Imaging Features and Clinicopathological Investigation of Steatohepatitic Hepatocellular Carcinoma.脂肪性肝炎相关肝细胞癌的对比增强成像特征及临床病理研究
Diagnostics (Basel). 2023 Apr 3;13(7):1337. doi: 10.3390/diagnostics13071337.
7
Current Imaging Diagnosis of Hepatocellular Carcinoma.肝细胞癌的当前影像诊断
Cancers (Basel). 2022 Aug 18;14(16):3997. doi: 10.3390/cancers14163997.
8
Current status of imaging biomarkers predicting the biological nature of hepatocellular carcinoma.影像生物标志物预测肝细胞癌生物学特性的现状。
Jpn J Radiol. 2019 Mar;37(3):191-208. doi: 10.1007/s11604-019-00817-3. Epub 2019 Feb 2.